Literature DB >> 2062508

Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps.

M L Friedberg1, U Pleyer, B J Mondino.   

Abstract

External devices have been used to enhance drug delivery. This article reviews the role of collagen shields, iontophoresis, and pumps used to deliver ophthalmic medications. Collagen shields have been used to deliver drugs and promote corneal epithelial healing. Presoaked collagen shields deliver many drugs to the eye as well as or better than traditional methods such as frequent topical therapy or subconjunctival injection. The efficacy of drug delivery by collagen shields was demonstrated in animal models of graft rejection and bacterial keratitis. Iontophoresis uses an electrical current to carry an ionized drug across tissue. Transcorneal iontophoresis delivers high concentrations of a drug to the anterior segment of the eye. Transscleral iontophoresis bypasses the lens-iris diaphragm and produces adequate vitreous levels. Pumps deliver fluid to the eye for extended periods of time via a tube with its distal opening in the conjunctival sac, corneal stroma, anterior chamber, or vitreous cavity. Clinical acceptance of the collagen shield for drug delivery to the anterior segment is better than iontophoresis or pumps, probably because the collagen shield is simpler and more convenient to use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062508     DOI: 10.1016/s0161-6420(91)32227-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Pharmacokinetics of ophthalmic corticosteroids.

Authors:  C N McGhee
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

3.  Iodide iontophoresis as a treatment for dry eye syndrome.

Authors:  J Horwath-Winter; O Schmut; E-M Haller-Schober; A Gruber; G Rieger
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 4.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

5.  Biocompatibility and drug release behavior of chitosan/poly (vinyl alcohol) corneal shield in vivo.

Authors:  Guo-Xing Li; Xin Gu; Hui-Yang Song; Kai-Hui Nan; Hao Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse.

Authors:  Hyesook Lee; Chae Eun Kim; Byul-Nim Ahn; Jaewook Yang
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

Review 7.  Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives.

Authors:  Ranjan Ku Sahoo; Nikhil Biswas; Arijit Guha; Nityananda Sahoo; Ketousetuo Kuotsu
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.